365660 — Lemon Healthcare Income Statement
0.000.00%
- KR₩48bn
- KR₩29bn
- KR₩16bn
Annual income statement for Lemon Healthcare, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 6,053 | 14,877 | 15,954 |
| Cost of Revenue | |||
| Gross Profit | — | 13,366 | 13,268 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 11,421 | 14,751 | 16,617 |
| Operating Profit | -5,368 | 127 | -663 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -8,892 | -2,898 | -2,100 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -8,892 | -2,898 | -2,100 |
| Net Income Before Extraordinary Items | |||
| Net Income | -8,892 | -2,898 | -2,100 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -8,892 | -2,898 | -2,100 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -666 | -217 | -157 |
| Dividends per Share |